Showing results (1041-1050 of 9,409) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|January 1, 1993
Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study GroupJ M Trang, L Kidd, W Gruber, et al.Clinical Pharmacology and Therapeutics|August 1, 1993
The pharmacokinetics of morphine and morphine glucuronides in kidney failureR Osborne, S Joel, K Grebenik, et al.Clinical Pharmacology and Therapeutics|August 1, 1993
Tricyclic antidepressants in red cells and plasma: correlation with impaired intraventricular conduction in acute overdoseY Amitai, T Erickson, E J Kennedy, et al.Clinical Pharmacology and Therapeutics|January 1, 1994
Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamineC S Stockley, L M Wing, A L Tonkin, et al.Clinical Pharmacology and Therapeutics|January 1, 1994
Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrationsJ I Schwartz, O L Laskin, C A Meeter, et al.Clinical Pharmacology and Therapeutics|January 1, 1993
A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylateT P Kruck, E A Fisher, D R McLachlanClinical Pharmacology and Therapeutics|January 1, 1993
Pharmacodynamic variability of flecainide assessed by QRS changesR Padrini, D Piovan, M Busa, et al.Clinical Pharmacology and Therapeutics|January 1, 1993
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trialE M Coutinho, J C de Souza, A R da Silva, et al.Clinical Pharmacology and Therapeutics|January 1, 1996
Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporineC M Stein, M T Kinirons, T Pincus, et al.Clinical Pharmacology and Therapeutics|January 1, 1996
Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodoneR F Kaiko, D P Benziger, R D Fitzmartin, et al.Pageof 941